Abstract
Review Aim: To analyze current data on neuroinvasion and neuroinflammation mechanisms in enterovirus infections underlying neurovirulence, and to comprehensively evaluate existing and emerging approaches for predicting adverse neurological outcomes of enteroviral meningitis (EVM) in children, focusing on biomarker discovery and risk stratification algorithm development.
Materials and Methods: We analyzed contemporary scientific literature on the pathogenesis of enterovirus infections, emphasizing neurotropism, neuroinvasion pathways, and intrathecal inflammation. We systematized data on prognostic methods, including instrumental diagnostics, cerebrospinal fluid and serum laboratory tests, and integrated mathematical models. Special attention was given to assessing the potential of chemiluminescent analysis for evaluating neutrophil functional-metabolic activity.
Results: Literature analysis revealed complex, complementary enterovirus neuroinvasion mechanisms driving neuroinflammation and determining the risk of long-term consequences. Modern prognostic approaches are diverse; however, comprehensive models integrating clinical-anamnestic, instrumental, and laboratory data provide the most accurate risk stratification. Assessment of neutrophil functional status using chemiluminescent analysis, particularly in cerebrospinal fluid, is a promising approach given their key role in neuroinvasion ("Trojan horse") and modulation of neuroinflammation in enteroviral meningitis. Respiratory burst parameters (activation rate, peak intensity, total reactive oxygen species (ROS) volume, activation index) may serve as early biomarkers of intrathecal inflammation severity, phagocytic reserve depletion, and complication risk.
Conclusion: The priority task is the development and validation of algorithms for predicting adverse outcomes of enteroviral meningitis in children, based on a combination of the most informative parameters. This includes promising indicators of cerebrospinal fluid neutrophil functional-metabolic activity assessed by chemiluminescent analysis. Implementing such algorithms will optimize clinical monitoring and rehabilitation strategies to minimize neurological deficits.
Introduction
Enteroviral meningitis (EVM) is a significant pediatric health concern, accounting for 85–90% of all cases of serous meningitis in children. While often classified as a "mild" or "serous" condition compared to bacterial meningitis, EVM is far from benign. Recent studies indicate that up to 70% of pediatric patients suffer from delayed neurological impairments, including cognitive deficits, chronic headaches (hypertension syndrome), and asthenia (chronic fatigue/weakness), months after clinical recovery.
The primary clinical challenge lies in the "silent" nature of these complications; standard clinical observations during the acute phase often fail to predict long-term outcomes. This review bridges the gap between basic virology—how the virus enters the brain—and clinical prognosis, highlighting the need for early, objective biomarkers to identify high-risk children.
Mechanisms of Neuroinvasion: The "Trojan Horse"
Enteroviruses utilize several sophisticated pathways to breach the central nervous system (CNS). While retrograde axonal transport and direct disruption of the blood-brain barrier (BBB) are known mechanisms, recent research emphasizes the "Trojan horse" method. In this scenario, the virus infects circulating immune cells—specifically monocytes and neutrophils—which then cross the BBB as part of the normal inflammatory response, inadvertently delivering the viral load into the CNS.
Because neutrophils are among the first responders, their functional state becomes a direct proxy for the intensity of the neuroinvasive process. Their over-activation leads to a "respiratory burst"—a rapid release of reactive oxygen species (ROS) intended to kill pathogens but which often causes significant collateral damage to brain tissue.
Diagnostic and Prognostic Approaches
Predicting the long-term neurological "aftershocks" of EVM requires a multi-modal approach. No single marker is a "silver bullet"; rather, the most accurate risk stratification comes from integrated mathematical models.
Instrumental Diagnostics
Tools such as Electroencephalography (EEG) and Transcranial Doppler (TCD) provide real-time data on cortical function and cerebral hemodynamics. Research has identified specific "danger zones," such as a linear blood flow velocity (Vm) in the basilar artery of less than 22 cm/s, which strongly correlates with the development of persistent focal symptoms.
Biochemical Profiling
Analyzing cerebrospinal fluid (CSF) and serum for markers of neuronal and glial damage is crucial. High levels of Neuron-Specific Enolase (NSE) and S-100 protein during the recovery phase indicate ongoing cellular damage, even when the child appears clinically well. Additionally, systemic inflammation markers like ferritin and various cytokines help characterize the overall inflammatory environment.
The Role of Chemiluminescent Analysis (CLA)
A highly promising, novel analytical approach involves the Chemiluminescent Analysis (CLA) of neutrophils. This method measures the intensity and timing of the respiratory burst. Key parameters include:
- Time to Peak Intensity ($T_{max}$): A shortened $T_{max}$ indicates "pre-activation" of the immune system, suggesting a high viral load or an aggressive early inflammatory state.
- Activation Index (AI): A significant drop in the AI signals an exhausted immune response and a depletion of the cellular reserve, both of which are linked to a higher risk of long-term complications.
Conclusion and Future Directions
The transition toward personalized medicine in pediatric meningitis necessitates the development of weighted scoring systems. By integrating real-time neutrophil activity (via CLA) with traditional CSF analysis and instrumental data, clinicians can create a robust risk profile for each patient.
The primary limitation remains the need for large-scale, prospective clinical trials to validate these chemiluminescent algorithms. Future work should focus on standardizing these protocols to ensure that high-risk children receive immediate and intensive rehabilitation, minimizing the long-term impact of enteroviral neuroinfection.
Summary updated